期刊
EXPERT REVIEW OF ANTICANCER THERAPY
卷 12, 期 2, 页码 229-242出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERA.11.205
关键词
adenovirus; clinical trial; herpes simplex virus; oncolytic virus; pediatric sarcoma; reovirus; Seneca Valley virus; vesicular stomatitis virus
类别
Oncolytic virotherapy has shown exciting promise for the treatment of many types of solid tumors. Pediatric sarcomas are an aggressive type of pediatric malignancy known to show limited responsiveness to current therapies, leading to unacceptably high morbidity and mortality. Oncolytic viruses have only recently been used for the treatment of this challenging cancer, and results have been encouraging. Five clinical trials are currently open evaluating the use of oncolytic viruses in pediatric malignancies. Advances in genetic engineering of the viruses include improving the ability of the virus to infect tumor cells, engineering the virus with transgenes which improve the virus' ability to kill tumor cells and manipulating the virus to enhance concomitantly administered therapies. Further understanding of the antiviral immune response and a viral induced anti-tumor immune response will permit a maximization of oncolytic virotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据